Skip to main content

Animations

MJFF Publications

5831 - 5840 of 8808 Results
Title
Year
  • Year
  • 2020
  • 2022
  • 2016
  • 2017
  • 2021
  • 2019
  • 2018
  • 2013
  • 2022
  • 2020
  • Summary Details
    OPEN
    Title: Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: A case series
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2020.105027
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Increased Phospho‐AKT in Blood Cells from LRRK2 G2019S Mutation Carriers
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/ana.26469
    Citation Count: 0
  • Summary Details
    OPEN
    Title: T2-Imaging Changes in the Nigrosome-1 Relate to Clinical Measures of Parkinson’s Disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2016.00174
    Citation Count: 10
  • Summary Details
    OPEN
    Title: The Neuroprotective Role of Protein Quality Control in Halting the Development of Alpha-Synuclein Pathology
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2017.00311
    Citation Count: 22
  • Summary Details
    OPEN
    Title: LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neurons
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1080/15548627.2021.1967615
    Citation Count: 41
  • Summary Details
    RESTRICTED
    Title: Anemia in men and increased Parkinson's disease risk: A population-based large scale cohort study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.03.010
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Impact of dyskinesia on activities of daily living in Parkinson's disease: Results from pooled phase 3 ADS-5102 clinical trials
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.09.005
    Citation Count: 29
  • Summary Details
    RESTRICTED
    Title: No PD Dyskinesia Scale Protects Against Placebo Responses: A Comparison of Multiple Scales (P04.187)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p04.187
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: A late-onset neurological disorder: is progression inevitable?
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.014
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: The footprint of orthostatic hypotension in parkinsonian syndromes
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.029
    Citation Count: 7
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.